IP Library Granted Patent US 12,350,156
Granted Patent B2
US 12,350,156 · App. 17/292,987 · Granted Jul 8, 2025

Atrioventricular valve repair

Inventors: Ehud Raanani (Hod Hasharon, IL); Boris Orlov (Rishon Letzion, IL)
Assignee: Sheba Impact Ltd.
A61F2/2466A61F2/2445A61B17/0218
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,350,156
App. No.
17/292,987
Granted
Jul 8, 2025
Kind
B2
Abstract

Apparatus and methods are described for use with an annuloplasty ring ( 20 ), and an atrioventricular valve of a heart of a mammalian subject, the atrioventricular valve including a valve annulus, valve leaflets, chords, and papillary muscles. A plurality of chord-manipulation arms ( 26 ) are configured to be deployed among the chords of the atrioventricular valve, and to cause a size of the valve annulus to decrease, by the chord-manipulation arms ( 26 ) being rotated such as to twist the native atrioventricular valve and pull the native atrioventricular valve radially inwards, by the chord-manipulation arms ( 26 ) deflecting the chords. The chord-manipulation arms ( 26 ) are configured to subsequently provide a counterforce against which the annuloplasty ring ( 20 ) is pushed, during implantation of the annuloplasty ring ( 20 ). Other applications are also described.

Claims (32)

1. Apparatus for treating an atrioventricular valve of a heart of a mammalian subject, the atrioventricular valve including a valve annulus and valve leaflets between an atrium of a heart and a ventricle of the heart, chords, and papillary muscles, the apparatus comprising:

an annuloplasty ring configured for implantation on the valve annulus in the atrium; and

a plurality of chord-manipulation arms configured:

for deployment, in the ventricle, among the chords of the atrioventricular valve;

subsequently, to cause a size of the valve annulus to decrease, by rotating such as to twist the native atrioventricular valve and pull the native atrioventricular valve radially inwards, by deflecting the chords; and

subsequently, to provide a counterforce, toward the atrium, against the annuloplasty ring during the implantation of the annuloplasty ring,

wherein at least portions of the chord-manipulation arms are configured to remain under the atrioventricular valve leaflets and the annuloplasty ring is configured to become anchored to the portions of the chord-manipulation arms;

wherein the portions are first portions, wherein the chord-manipulation arms further comprise second portions, and wherein the first portions of the chord-manipulation arms are configured to be detachable from the second portions of the chord-manipulation arms, and are configured to remain under the atrioventricular valve leaflets even after the second portions of the chord-manipulation arms are removed from the subject's ventricle.

2. The apparatus according to claim 1 , wherein the chord-manipulation arms are configured, subsequently to the implantation, to untwist the native atrioventricular valve by rotating in an opposite direction to the direction of the rotation of the chord-manipulation arms that caused the native atrioventricular valve to become twisted.

3. The apparatus according to claim 1 , wherein the atrioventricular valve includes a mitral valve, and the chord-manipulation arms are configured for deployment among chords of the mitral valve.

4. The apparatus according to claim 1 , wherein the atrioventricular valve includes a tricuspid valve, and the chord-manipulation arms are configured for deployment among chords of the tricuspid valve.

5. The apparatus according to claim 1 , wherein the chord-manipulation arms are sized such that, when disposed in radially-non-constrained configurations, the chord-manipulation arms span a diameter that is at least equal to an inner diameter of the annuloplasty ring, such that the chord-manipulation arms are configured to provide the counterforce during the implantation of the annuloplasty ring.

6. The apparatus according to claim 1 , wherein the chord-manipulation arms are sized such that, when disposed in radially-non-constrained configurations, the chord-manipulation arms are configured to overlap radially with the annuloplasty ring, such that the chord-manipulation arms are configured to provide the counterforce during the implantation of the annuloplasty ring.

7. The apparatus according to claim 1 , wherein at least a portion of an inner edge of each of the chord-manipulation arms is concavely curved in a given circumferential direction, and wherein the chord-manipulation arms are configured to pull the native atrioventricular valve radially inwards, by rotating in the given circumferential direction.

8. The apparatus according to claim 1 , wherein the annuloplasty ring comprises a plurality of anchoring elements, and wherein at least some of the anchoring elements are configured to become embedded in the chord-manipulation arms.

9. The apparatus according to claim 1 , further comprising a frame configured to extend from the ventricle into the atrium of the subject's heart, the frame defining holes which are sized such as to allow blood to flow from the atrium to the ventricle of the subject's heart via the frame, and wherein the chord-manipulation arms are coupled to a portion of the frame that is configured to be disposed within the ventricle.

10. The apparatus according to claim 1 ,

further comprising a support rod and a hollow tube that define holes,

wherein the chord-manipulation arms are coupled to the support rod and the support rod is configured to be disposed inside the hollow tube, and

wherein the holes within the hollow tube are sized such as to allow blood to flow from the atrium of the subject's heart to the ventricle of the subject's heart via the hollow tube.

11. The apparatus according to claim 10 , further comprising a unidirectional valve disposed within the hollow tube, and configured to allow blood flow from the atrium to the ventricle, but to block blood flow in the opposite direction.

12. The apparatus according to claim 1 , further comprising a delivery device configured to deliver the chord-manipulation arms to the ventricle of the subject's heart, wherein the arms are disposed at an angle of between 45 degrees and 135 degrees with respect to a longitudinal axis of a distal-most portion of the delivery device.

13. The apparatus according to claim 1 , further comprising a plurality of support elements, wherein each of the chord-manipulation arms is coupled to a respective one of the support elements, and wherein, during the deployment of the arms inside the ventricle, the support elements are configured to separate from each other.

14. A method for use with an annuloplasty ring, and an atrioventricular valve of a heart of a mammalian subject, the atrioventricular valve including a valve annulus and valve leaflets between an atrium of a heart and a ventricle of the heart, chords, and papillary muscles, the method comprising:

deploying a plurality of chord-manipulation arms in the ventricle among the chords of the atrioventricular valve;

subsequently rotating the arms, such that the arms cause a size of the valve annulus to decrease, by the arms twisting the native atrioventricular valve and pulling the native atrioventricular valve radially inwards, by deflecting the chords; and

subsequently, implanting the annuloplasty ring on the valve annulus in the atrium, while using the arms (a) to maintain the size of the valve annulus at its decreased size, by maintaining the arms in their rotated state, and (b) to provide a counterforce, toward the atrium, against the annuloplasty ring, by pulling the arms from beneath the valve leaflets toward the annuloplasty ring.

15. The method according to claim 14 , further comprising, subsequent to implanting the annuloplasty ring on the valve annulus, allowing the native atrioventricular valve to become untwisted by rotating the chord-manipulation arms in an opposite direction to the direction of the rotation of the chord-manipulation arms that caused the native atrioventricular valve to become twisted.

16. The method according to claim 14 , wherein the atrioventricular valve includes a mitral valve, and deploying the plurality of chord-manipulation arms among the chords of the atrioventricular valve comprises deploying the plurality of chord-manipulation arms among chords of the mitral valve.

17. The method according to claim 14 , wherein the atrioventricular valve includes a tricuspid valve, and deploying the plurality of chord-manipulation arms among the chords of the atrioventricular valve comprises deploying the plurality of chord-manipulation arms among chords of the tricuspid valve.

18. The method according to claim 14 , wherein deploying the plurality of chord-manipulation arms among the chords of the atrioventricular valve comprises deploying the arms among the chords of the atrioventricular valve such that the arms span a diameter that is at least equal to an inner diameter of the annuloplasty ring, such that the arms are configured to provide a counterforce against which the annuloplasty ring is pushed, during implantation of the annuloplasty ring.

19. The method according to claim 14 , wherein deploying the plurality of chord-manipulation arms among the chords of the atrioventricular valve comprises deploying the arms among the chords of the atrioventricular valve such that the arms overlap radially with the annuloplasty ring, such that the arms are configured to provide a counterforce against which the annuloplasty ring is pushed, during implantation of the annuloplasty ring.

Assignments (2)
CHANGE OF NAME Recorded Jun 2, 2025
From: TEL HASHOMER MEDICAL RESEARCH, INFRASTRUCTURE AND SERVICES LTD.
To: SHEBA IMPACT LTD.
Reel/Frame 071494/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2021
From: RAANANI, EHUD; ORLOV, BORIS
To: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Reel/Frame 056208/0261 →
Continuity (2)
Provisional Application 62767018 · Nov 14, 2018
Related Publication 20220015905A1 · Jan 20, 2022
References Cited (256)
US 6270520B1 · Inoue · 2001 [cited by applicant]
US 7018408B2 · Bailey et al. · 2006 [cited by applicant]
US 7621948B2 · Herrmann et al. · 2009 [cited by applicant]
US 7748389B2 · Salahieh et al. · 2010 [cited by applicant]
US 7753949B2 · Lamphere et al. · 2010 [cited by applicant]
US 8070802B2 · Lamphere et al. · 2011 [cited by applicant]
US 8870950B2 · Hacohen · 2014 [cited by applicant]
US 9364326B2 · Yaron · 2016 [cited by applicant]
US 9700412B2 · Yaron et al. · 2017 [cited by applicant]
US 9949830B2 · Solem · 2018 [cited by applicant]
US 10105217B2 · Keränen · 2018 [cited by applicant]
US 10130471B2 · Keränen et al. · 2018 [cited by applicant]
US 10238489B2 · Conklin · 2019 [cited by applicant]
US 10292816B2 · Raanani et al. · 2019 [cited by applicant]
US 10292850B2 · Vad et al. · 2019 [cited by applicant]
US 10500038B1 · Orlov et al. · 2019 [cited by applicant]
US 11065114B2 · Raanani et al. · 2021 [cited by applicant]
US 11583394B2 · Orlov et al. · 2023 [cited by applicant]
US 11779459B2 · Raanani et al. · 2023 [cited by applicant]
US 20020065554A1 · Streeter · 2002 [cited by applicant]
US 20030014104A1 · Cribier · 2003 [cited by applicant]
US 20030083742A1 · Spence et al. · 2003 [cited by applicant]
US 20040138745A1 · Macoviak et al. · 2004 [cited by applicant]
US 20050165479A1 · Drews et al. · 2005 [cited by applicant]
US 20060195134A1 · Crittenden · 2006 [cited by applicant]
US 20060195184A1 · Lane et al. · 2006 [cited by applicant]
US 20060241745A1 · Solem · 2006 [cited by applicant]
US 20070016288A1 · Gurskis et al. · 2007 [cited by applicant]
US 20070050020A1 · Spence · 2007 [cited by applicant]
US 20070260305A1 · Drews et al. · 2007 [cited by applicant]
US 20080039935A1 · Buch et al. · 2008 [cited by applicant]
US 20090192585A1 · Bloom et al. · 2009 [cited by applicant]
US 20090192586A1 · Tabor et al. · 2009 [cited by applicant]
US 20090198324A1 · Orlov · 2009 [cited by applicant]
US 20100022640A1 · Stoutamire · 2010 [cited by applicant]
US 20100042208A1 · Herrmann et al. · 2010 [cited by applicant]
US 20100049313A1 · Alon et al. · 2010 [cited by applicant]
US 20100249923A1 · Alkhatib et al. · 2010 [cited by applicant]
US 20100331971A1 · Keraenen et al. · 2010 [cited by applicant]
US 20110029072A1 · Gabbay · 2011 [cited by applicant]
US 20110137397A1 · Chau et al. · 2011 [cited by applicant]
US 20110137410A1 · Hacohen · 2011 [cited by applicant]
US 20110224785A1 · Hacohen · 2011 [cited by applicant]
US 20110264208A1 · Duffy et al. · 2011 [cited by applicant]
US 20120010461A1 · Goldfarb et al. · 2012 [cited by applicant]
US 20120022639A1 · Hacohen et al. · 2012 [cited by applicant]
US 20120022640A1 · Gross et al. · 2012 [cited by applicant]
US 20120101571A1 · Thambar et al. · 2012 [cited by applicant]
US 20130035759A1 · Gross et al. · 2013 [cited by applicant]
US 20130166022A1 · Conklin · 2013 [cited by applicant]
US 20140031928A1 · Murphy et al. · 2014 [cited by applicant]
US 20140088695A1 · Figulla et al. · 2014 [cited by applicant]
US 20140088696A1 · Figulla et al. · 2014 [cited by applicant]
US 20140222136A1 · Geist et al. · 2014 [cited by applicant]
US 20140379074A1 · Spence · 2014 [cited by examiner]
US 20150045880A1 · Hacohen · 2015 [cited by applicant]
US 20150173897A1 · Raanani · 2015 [cited by examiner]
US 20150351903A1 · Morriss et al. · 2015 [cited by applicant]
US 20150351908A1 · Kernen et al. · 2015 [cited by applicant]
US 20150359628A1 · Keränen · 2015 [cited by applicant]
US 20150374493A1 · Yaron et al. · 2015 [cited by applicant]
US 20160045306A1 · Agrawal et al. · 2016 [cited by applicant]
US 20160095705A1 · Keränen et al. · 2016 [cited by applicant]
US 20170128199A1 · Gurovich et al. · 2017 [cited by applicant]
US 20170281338A1 · Quill et al. · 2017 [cited by applicant]
US 20180014932A1 · Hammer et al. · 2018 [cited by applicant]
US 20180125651A1 · Nasr · 2018 [cited by applicant]
US 20180177594A1 · Patel et al. · 2018 [cited by applicant]
US 20180206992A1 · Brown · 2018 [cited by applicant]
US 20190083245A1 · Hariton et al. · 2019 [cited by applicant]
US 20190110893A1 · Haarer et al. · 2019 [cited by applicant]
US 20190125534A1 · Arcaro et al. · 2019 [cited by applicant]
US 20190231520A1 · Desrosiers et al. · 2019 [cited by applicant]
US 20190231522A1 · Raanani et al. · 2019 [cited by applicant]
US 20200100898A1 · Vola et al. · 2020 [cited by applicant]
US 20200121454A1 · Spence · 2020 [cited by applicant]
US 20200197175A1 · Chang et al. · 2020 [cited by applicant]
US 20220010634A1 · Posa · 2022 [cited by applicant]
US 20220015896A1 · Agian et al. · 2022 [cited by applicant]
US 20220015905A1 · Raanani et al. · 2022 [cited by applicant]
US 20220296370A1 · Agian et al. · 2022 [cited by applicant]
US 20230000622A1 · Raanani et al. · 2023 [cited by applicant]
US 20230172707A1 · Orlov et al. · 2023 [cited by applicant]
CA 2606101A1 · 2006 [cited by applicant]
CA 2898991A1 · 2014 [cited by applicant]
CN 101180010A · 2008 [cited by applicant]
CN 102292053A · 2011 [cited by applicant]
CN 102438546A · 2012 [cited by applicant]
CN 104684505A · 2015 [cited by applicant]
CN 104994812A · 2015 [cited by applicant]
DE 102006052564 · 2007 [cited by applicant]
EP 1850796B1 · 2015 [cited by applicant]
EP 3399947A1 · 2018 [cited by applicant]
EP 2948102B1 · 2019 [cited by applicant]
EP 2852354B1 · 2020 [cited by applicant]
JP 2008536592A · 2008 [cited by applicant]
JP 2011509806A · 2011 [cited by applicant]
JP 2012500665A · 2012 [cited by applicant]
JP 2012521222A · 2012 [cited by applicant]
JP 2014168694A · 2014 [cited by applicant]
JP 2015517376A · 2015 [cited by applicant]
JP 2016504134A · 2016 [cited by applicant]
JP 2018501001A · 2018 [cited by applicant]
JP 2019500965A · 2019 [cited by applicant]
JP 7051736B2 · 2022 [cited by applicant]
WO 0060995A2 · 2000 [cited by applicant]
WO 2004032724A2 · 2004 [cited by applicant]
WO 2005087140A1 · 2005 [cited by applicant]
WO 2006116558A2 · 2006 [cited by applicant]
WO 2007135101A1 · 2007 [cited by applicant]
WO 2009134701A2 · 2009 [cited by applicant]
WO 2010108079A1 · 2010 [cited by applicant]
WO 2012004679A2 · 2012 [cited by applicant]
WO 2012095116A1 · 2012 [cited by applicant]
WO 2013001339A2 · 2013 [cited by applicant]
WO 2013175468A2 · 2013 [cited by applicant]
WO 2014114795A1 · 2014 [cited by applicant]
WO 2015198125A1 · 2015 [cited by applicant]
WO 2018109329A1 · 2018 [cited by applicant]
WO 2018112429A1 · 2018 [cited by applicant]
WO 2020092096A2 · 2020 [cited by applicant]
WO 2020100050A1 · 2020 [cited by applicant]
WO 2021028867A1 · 2021 [cited by applicant]
WO 2022090881A1 · 2022 [cited by applicant]
WO 2022090882A1 · 2022 [cited by applicant]
WO 2022234468A1 · 2022 [cited by applicant]
WO 2022264082A1 · 2022 [cited by applicant]
WO 2023228028A1 · 2023 [cited by applicant]
WO 2024057226A1 · 2024 [cited by applicant]
Extended European Search Report for European Application No. 23162937.9 mailed Jun. 21, 2023. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/349,152 mailed May 24, 2023. [cited by applicant]
Office Action for Canadian Application No. 3,149,527 mailed Mar. 6, 2023. [cited by applicant]
U.S. Appl. No. 16/106,000, filed Oct. 27, 2020. [cited by applicant]
U.S. Appl. No. 16/106,034, filed Oct. 27, 2020. [cited by applicant]
U.S. Appl. No. 18/248,394, filed Apr. 10, 2023. [cited by applicant]
U.S. Appl. No. 63/106,000, filed Oct. 27, 2020. [cited by applicant]
U.S. Appl. No. 63/106,034, filed Oct. 27, 2020. [cited by applicant]
Advisory Action for U.S. Appl. No. 14/402,387 mailed Mar. 1, 2018. [cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Jan. 8, 2018 From the European Patent Office Re. Application No. 13732633.6. [cited by applicant]
Communication Relating to the Results of the Partial International Search Dated Nov. 18, 2013 From the International Searching Authority Re. Application No. PCT/IL2013/050432. [cited by applicant]
Corrected Notice of Allowability for U.S. Appl. No. 14/402,387 mailed Mar. 20, 2019. [cited by applicant]
Examination Report for Australian Application No. 2013264730 mailed Dec. 20, 2017. [cited by applicant]
Examination Report for Australian Application No. 2013264730 mailed Jan. 13, 2017. [cited by applicant]
Examination Report for Australian Application No. 2018202951 mailed Dec. 6, 2018. [cited by applicant]
Examination Report for Australian Application No. 2019250140 mailed Oct. 19, 2020. [cited by applicant]
Examination Report for European Application No. 13732633.6 mailed Aug. 8, 2019. [cited by applicant]
Examination Report for Indian Application No. 2424/MUMNP/2014 mailed Aug. 31, 2020. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/402,387 mailed Oct. 2, 2017. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/475,994 mailed Jan. 10, 2017. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/475,994 mailed Jun. 10, 2015. [cited by applicant]
International Preliminary Report on Patentability from International Application No. PCT/IL2013/050432 mailed Dec. 4, 2014. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2019/059734 mailed Feb. 6, 2020. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2020/057636 mailed Oct. 29, 2020. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2013/050432 mailed Feb. 26, 2014. [cited by applicant]
Issue Notification for U.S. Appl. No. 14/402,387 mailed May 1, 2019. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/475,994 mailed Apr. 1, 2016. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/475,994 mailed Oct. 1, 2014. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/475,994 mailed Sep. 11, 2017. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/402,387 mailed Dec. 23, 2016. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/402,387 mailed Sep. 20, 2018. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 14/402,387 mailed Apr. 30, 2019. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 14/402,387 mailed Jan. 30, 2019. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/374,240 mailed Mar. 16, 2021. [cited by applicant]
Notice of Amendment Dated Jun. 23, 2017 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710425696.6 and Its Machine Translation Into English. [cited by applicant]
Notice of Reason for Rejection Dated Feb. 14, 2017 From the Japan Patent Office Re. Application No. 2015-513347 and Translation. [cited by applicant]
Notification of Office Action and Search Report Dated Sep. 7, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0. [cited by applicant]
Notification of Office Action Dated Dec. 3, 2015 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0. [cited by applicant]
Notification of Office Action Dated Dec. 14, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0 and Its Translation Into English. [cited by applicant]
Office Action for Australian Application No. 2018202951 mailed Apr. 1, 2019. [cited by applicant]
Office Action for Canadian Application No. 2,874,208 mailed Aug. 2, 2019. [cited by applicant]
Office Action for Canadian Application No. 2,874,208 mailed Feb. 19, 2019. [cited by applicant]
Office Action for Chinese Application No. 20170425696.6 mailed May 19, 2020. [cited by applicant]
Office Action for Chinese Application No. 201710425696.6 mailed Nov. 4, 2019. [cited by applicant]
Office Action for Japanese Application No. 2017-184962 mailed Jul. 31, 2018. [cited by applicant]
Office Action for Japanese Application No. 2019/032726 mailed Feb. 18, 2020. [cited by applicant]
Office Action for Japanese Application No. 2019/032726 mailed Jan. 19, 2021. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 13/475,994 mailed Mar. 11, 2014. [cited by applicant]
Translation Dated Dec. 28, 2015 of Notification of Office Action Dated Dec. 3, 2015 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0. [cited by applicant]
Translation of Notification of Office Action and Search Report Dated Sep. 7, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0. [cited by applicant]
U.S. Appl. No. 12/582,986, filed Oct. 21, 2009. [cited by applicant]
U.S. Appl. No. 14/402,387, filed Nov. 20, 2014. [cited by applicant]
U.S. Appl. No. 16/374,240, filed Apr. 3, 2019. [cited by applicant]
U.S. Appl. No. 61/649,319, filed May 20, 2012. [cited by applicant]
U.S. Appl. No. 62/767,018, filed Nov. 14, 2018. [cited by applicant]
U.S. Appl. No. 62/886,366, filed Aug. 14, 2019. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/402,387 mailed Dec. 28, 2017. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 14/402,387 mailed May 25, 2017. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/083,643 mailed Mar. 5, 2014. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/475,994 mailed Jun. 8, 2018. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2023/055160 mailed Jul. 28, 2023. [cited by applicant]
Issue Notification for U.S. Appl. No. 13/475,994 mailed Nov. 20, 2019. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/655,656 mailed Feb. 1, 2023. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/349,152 mailed Sep. 20, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 13/475,994 mailed Dec. 28, 2018. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/263,776 mailed Oct. 25, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/488,623 mailed Oct. 26, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/488,628 mailed Oct. 26, 2023. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 13/475,994 mailed Jul. 22, 2019. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/655,656 mailed Oct. 25, 2022. [cited by applicant]
Office Action for Japanese Application No. 2021-525788 mailed Nov. 1, 2023. [cited by applicant]
U.S. Appl. No. 13/475,994, filed May 20, 2012. [cited by applicant]
U.S. Appl. No. 16/655,656, filed Oct. 17, 2019. [cited by applicant]
U.S. Appl. No. 17/263,776, filed Jan. 27, 2021. [cited by applicant]
U.S. Appl. No. 18/103,671, filed Jan. 31, 2023. [cited by applicant]
U.S. Appl. No. 61/488,180 filed May 20, 2011. [cited by applicant]
U.S. Appl. No. 63/211,602, filed Jun. 17, 2021. [cited by applicant]
Examination Report for Indian Application No. 20217021772 mailed Jan. 11, 2023. [cited by applicant]
Hearing Notice for Indian Application No. 2424/MUMNP/2014 mailed Jan. 3, 2023. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2019/059734 mailed Jan. 30, 2020. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2022/054099 mailed Sep. 12, 2022. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2022/055593 mailed Nov. 14, 2022. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/IB2022/054099 mailed Jul. 20, 2022. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/IB2022/055593 mailed Sep. 23, 2022. [cited by applicant]
U.S. Appl. No. 17/349,152, filed Jun. 16, 2021. [cited by applicant]
U.S. Appl. No. 17/488,623, filed Sep. 29, 2021. [cited by applicant]
U.S. Appl. No. 17/488,628, filed Sep. 29, 2021. [cited by applicant]
U.S. Appl. No. 17/932,014, filed Sep. 14, 2022. [cited by applicant]
U.S. Appl. No. 63/184,403, filed May 5, 2021. [cited by applicant]
U.S. Appl. No. 63/184,427, filed May 5, 2021. [cited by applicant]
Communication Pursuant to Rule 94(3) for European Patent Application No. 20760551.0 mailed Apr. 7, 2022. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/IB2021/059798 mailed Jan. 24, 2022. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/IB2021/059799 mailed Jan. 25, 2022. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/374,240 mailed Jun. 30, 2021. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/655,656 mailed Jun. 17, 2022. [cited by applicant]
Office Action for Japanese Application No. 2019/032726 mailed Nov. 19, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/488,628 mailed Jul. 31, 2024. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/103,671 mailed Jul. 29, 2024. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/488,623 mailed Jul. 31, 2024. [cited by applicant]
Examination Report for Indian Application No. 202247005897 mailed Dec. 11, 2024. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2024/052304 mailed Jun. 17, 2024. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/488,628 mailed Oct. 23, 2024. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/932,014 mailed Sep. 4, 2024. [cited by applicant]
Issue Notification for U.S. Appl. No. 18/103,671 mailed Jan. 8, 2025. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/488,623 mailed Jan. 6, 2025. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/103,671 mailed Sep. 28, 2024. [cited by applicant]
Office Action for Chinese Application No. 201980082413.X mailed Sep. 26, 2024. [cited by applicant]
Office Action for Israel Application No. 283093 mailed Jan. 16, 2025. [cited by applicant]
Office Action for Israel Application No. 290306 mailed Jul. 7, 2024. [cited by applicant]
U.S. Appl. No. 18/814,988, filed Aug. 26, 2024. [cited by applicant]
U.S. Appl. No. 18/867,696, filed Nov. 20, 2024. [cited by applicant]
U.S. Appl. No. 18/994,876, filed Jan. 15, 2025. [cited by applicant]
U.S. Appl. No. 18/999,207, filed Dec. 23, 2024. [cited by applicant]
U.S. Appl. No. 63/344,590, filed May 22, 2022. [cited by applicant]
U.S. Appl. No. 63/405,966, filed Sep. 13, 2022. [cited by applicant]
Examination Report for European Application No. 21801644.2 mailed May 2, 2024. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/488,623 mailed May 30, 2024. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2023/059084 mailed Feb. 12, 2024. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/IB2023/059084 mailed Dec. 22, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/488,628 mailed May 31, 2024. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/103,671 mailed Apr. 2, 2024. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/263,776 mailed Apr. 9, 2024. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/932,014 mailed May 22, 2024. [cited by applicant]
Office Action for Chinese Application No. 201980082413 mailed Jan. 31, 2024. [cited by applicant]
Office Action for Israel Application No. 283093 mailed Feb. 18, 2024. [cited by applicant]
Office Action for Japanese Application No. 2021-525788 mailed Mar. 11, 2024. [cited by applicant]
Office Action for Japanese Application No. 2022-508890 mailed Apr. 9, 2024. [cited by applicant]